# Xtrackers MSCI Europe Screened UCITS ETF -1C- Capitalisation (XEUM)

**Page:** https://fundology.uk/fund/xeum · ISIN LU0322253732

## At a glance

> Capital at risk. Past performance is not a guide to future returns. The value of investments can fall as well as rise.

As of 13/11/2026, XEUM (Xtrackers MSCI Europe Screened UCITS ETF -1C- Capitalisation, ISIN LU0322253732) closed at £180.38 on the London Stock Exchange. Its ongoing charge is 0.12% a year (about £12 on £10,000). Over the five years to 13/11/2026 its total return was +47.7%, or +15.3% after UK CPIH inflation.

## Summary

Xtrackers MSCI Europe Screened UCITS ETF -1C- Capitalisation is an exchange-traded fund (ETF) from Xtrackers, launched in 2008. It tracks the MSCI Europe Select ESG Screened Index — large and medium-sized European companies. You buy and sell it through a share-dealing account or platform during stock-market hours, like a share. Its ongoing charge is 0.12% a year — about £12 a year on every £10,000 invested, taken from the fund's value rather than billed to you. Income from its investments is reinvested inside the fund, so it shows up as a rising price rather than cash paid to you.

Latest close: **£180.38** (13/11/2026).

## Key facts

| Fact | Value |
|---|---|
| Ticker (LSE) | XEUM |
| ISIN | LU0322253732 |
| Also listed as | DX2I (Xetra, euros) |
| Category | European shares |
| Type | ETF |
| Provider | Xtrackers |
| Tracks | MSCI Europe Select ESG Screened Index |
| Income | Accumulating |
| Ongoing charge | 0.12% a year (£12 per £10,000) |
| Fund size | £73.3m |
| Launched | 2008 |
| Domicile | Luxembourg |
| UK reporting fund status | Yes — on HMRC’s list of reporting funds (list of 02/11/2026); reporting fund since 01/01/2011 |

## Past returns (periods to 13/11/2026)

After the fund's ongoing charges. "Income reinvested" is total return; "price only" leaves out income paid out. Real returns are after UK CPIH inflation.

| Window | Return | After CPIH inflation | Measured as |
|---|---|---|---|
| 1 year | +10.97% | +7.04% | income reinvested |
| 3 years | +49.35% | +34.93% | income reinvested |
| 5 years | +47.73% | +15.31% | income reinvested |

Returns: as reported (delayed data). Inflation: UK CPIH, latest month published.

## Calendar-year returns

Calendar-year returns of Xtrackers MSCI Europe Screened UCITS ETF -1C- Capitalisation in pounds (price, with income reinvested in the fund): 2022 −5.3%, 2023 +14.0%, 2024 +3.0%, 2025 +23.0%; 2026 to 13/11/2026 +9.5%. Returns of Xtrackers MSCI Europe Screened UCITS ETF -1C- Capitalisation in pounds (price, with income reinvested in the fund) over the 12 months to 30/09/2026: +11.6%; to 30/09/2025: +12.2%; to 30/09/2024: +16.0%; to 30/09/2023: +18.8%; to 30/09/2022: −10.6%.

| Year | Return | After CPIH inflation | Measured as |
|---|---|---|---|
| 2022 | -5.3% | -13.3% | Price |
| 2023 | +14.0% | +9.5% | Price |
| 2024 | +3.0% | -0.5% | Price |
| 2025 | +23.0% | +18.8% | Price |
| 2026 to 13/11/2026 | +9.5% | +6.0% | Price |

## Risk metrics

| Window | Volatility | Max drawdown |
|---|---|---|
| 1 year | 13.45% | -10.70% |
| 3 years | 12.01% | -10.70% |
| 5 years | 13.64% | -16.52% |

## Largest fall

Volatility of Xtrackers MSCI Europe Screened UCITS ETF -1C- Capitalisation in pounds, annualised from weekly returns to 13/11/2026: 13.4% over 1 year, 12.0% over 3 years, 13.6% over 5 years. Largest fall in the price of Xtrackers MSCI Europe Screened UCITS ETF -1C- Capitalisation since November 2021, in pounds: −15.4% from 31/12/2021 to 30/09/2022. The lowest 12-month return of Xtrackers MSCI Europe Screened UCITS ETF -1C- Capitalisation in pounds (price, with income reinvested in the fund) since January 2021 was −11.7% (12 months to 14/10/2022); the highest was +26.8% (12 months to 17/04/2026). On 13/11/2026 the price of Xtrackers MSCI Europe Screened UCITS ETF -1C- Capitalisation was 0.7% below its highest weekly close since November 2021 (05/08/2026), in pounds.

## Charges compared with similar funds

Ongoing charge of Xtrackers MSCI Europe Screened UCITS ETF -1C- Capitalisation 0.12% a year. Compared on 14/11/2026, 187 of the 242 other European share funds charge more, 17 the same and 38 less (share classes counted once).

## Charges & eligibility

- Ongoing charges figure (OCF): **0.12%** per year
- Stocks and shares ISA eligible: usually (check with your platform)
- SIPP eligible: usually (check with your provider)
- ISA and SIPP mean the kind of product usually qualifies under HMRC rules. We do not check each platform’s list — each provider decides which funds it offers. Crypto ETNs have not qualified for a stocks and shares ISA since 06/04/2026, and overseas funds that are not UK-recognised UCITS, such as Swiss ETFs, do not usually qualify.

## What it holds

As of 15/11/2026, XEUM holds 361 positions, according to its published holdings. The largest is ASML at 4.70% of the fund; the ten largest make up 23.2%.

### Top holdings

Largest positions (as of 15/11/2026), as a percentage of the whole fund:

| # | Holding | Ticker | Weight |
|---|---|---|---|
| 1 | ASML | [ASML](https://fundology.uk/stock/ASML) | 4.70% |
| 2 | Roche | [RO](https://fundology.uk/stock/RO) | 2.72% |
| 3 | Novartis | [NOVN](https://fundology.uk/stock/NOVN) | 2.34% |
| 4 | TotalEnergies | [TTE](https://fundology.uk/stock/TTE) | 2.31% |
| 5 | HSBC | [HSBA](https://fundology.uk/stock/HSBA) | 2.29% |
| 6 | AstraZeneca | [AZN](https://fundology.uk/stock/AZN) | 2.22% |
| 7 | SAP | [SAP](https://fundology.uk/stock/SAP) | 1.89% |
| 8 | Siemens | [SIE](https://fundology.uk/stock/SIE) | 1.84% |
| 9 | Allianz | [ALV](https://fundology.uk/stock/ALV) | 1.48% |
| 10 | L'Oréal | [OR](https://fundology.uk/stock/OR) | 1.45% |

## Where it invests

Shares of the whole fund. Bonds, cash and positions without a classification are shown as they come, not guessed.

### By sector

Added up from the fund’s published holdings, as of 15/11/2026.

| Sector | Weight |
|---|---|
| Financials | 25.7% |
| Industrials | 17.2% |
| Health Care | 15.1% |
| Information Technology | 9.5% |
| Consumer Staples | 8.1% |
| Utilities | 5.4% |
| Consumer Discretionary | 5.3% |
| Materials | 5.3% |
| Other sectors | 8.3% |
| Not classified | 0.1% |

### By country

Added up from the fund’s published holdings, as of 15/11/2026.

| Country | Weight |
|---|---|
| United Kingdom | 18.8% |
| France | 15.0% |
| Switzerland | 13.9% |
| Germany | 13.3% |
| Netherlands | 9.8% |
| Italy | 5.6% |
| Spain | 5.5% |
| Sweden | 5.4% |
| Other countries | 12.6% |
| Not classified | 0.1% |

### By type of asset

Added up from the fund’s published holdings, as of 15/11/2026.

| Type of asset | Weight |
|---|---|
| Equity | 100.0% |
| Cash and money market | 0.1% |

The 360 holdings on record (of 361 reported): https://fundology.uk/fund/xeum/holdings

## Questions people ask

**What is the ongoing charge of XEUM?**

The ongoing charge of XEUM is 0.12% a year — about £12 a year on every £10,000 invested, taken from the fund’s value rather than billed to you. Platform and dealing fees are charged separately. Ongoing charge of Xtrackers MSCI Europe Screened UCITS ETF -1C- Capitalisation 0.12% a year. Compared on 14/11/2026, 187 of the 242 other European share funds charge more, 17 the same and 38 less (share classes counted once).

**What does XEUM track?**

XEUM tracks the MSCI Europe Select ESG Screened Index — large and medium-sized European companies.

**Is XEUM accumulating or distributing?**

XEUM is accumulating: income is reinvested inside the fund, so it shows up as a rising price rather than cash paid to you.

**What is the ISIN of XEUM?**

The ISIN of XEUM is LU0322253732. An ISIN identifies one exact share class of a fund; XEUM is its ticker on the London Stock Exchange. The same share class is also listed as DX2I (Xetra, euros).

**What does XEUM hold?**

As of 15/11/2026, XEUM holds 361 positions, according to its published holdings. The largest is ASML at 4.70% of the fund; the ten largest make up 23.2%. Its ten largest holdings are ASML (4.70%), Roche (2.72%), Novartis (2.34%), TotalEnergies (2.31%), HSBC (2.29%), AstraZeneca (2.22%), SAP (1.89%), Siemens (1.84%), Allianz (1.48%) and L'Oréal (1.45%).

**What were XEUM’s returns in each of the last five years?**

Calendar-year returns of XEUM in pounds (price, with income reinvested in the fund): 2022 −5.3%, 2023 +14.0%, 2024 +3.0%, 2025 +23.0%; 2026 to 13/11/2026 +9.5%. Past performance is not a guide to future returns.

**How has XEUM done after inflation?**

Over the five years to 13/11/2026 XEUM’s total return was +47.7%, or +15.3% after UK CPIH inflation. Past performance is not a guide to future returns.

## Fund documents

- [Fund page at Xtrackers (DWS)](https://etf.dws.com/en-gb/LU0322253732-msci-europe-screened-ucits-etf-1c/)
- Links checked 12/10/2026.

---

We show information. We are not financial advisers, not authorised by the FCA, and never recommend specific investments.

Capital at risk. Past performance is not a guide to future returns. The value of investments can fall as well as rise.